Don't want ads? Subscribe or login now.

Chinese Regulators OK $43B Medtronic-Covidien Inversion

By Karlee Weinmann · December 4, 2014, 2:38 PM EST

Medtronic Inc. and Covidien PLC inched closer to completing their $42.9 billion tax-inversion deal on Thursday with approval from Chinese regulators, wrapping up the controversial transaction's antitrust review and turning the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Karlee

January 29, 2015
Icahn-Targeted Manitowoc Agrees To Split Operations
January 29, 2015
January Brings Clarity To Some Of 2014's Buzziest M&A Moves
January 26, 2015
With Irish Court's OK, Medtronic Completes $50B Inversion
January 12, 2015
$2B Steris Inversion Could Be Delayed By Deeper FTC Probe
January 08, 2015
MeadWestvaco Latest To Bow To Activist With Spinoff
January 06, 2015
Investors Cheer $48B Medtronic Deal, Biggest Inversion Yet
January 05, 2015
$48B Medtronic Inversion Faces Blowback As It Heads To Vote
December 22, 2014
The Biggest M&A Moments Of 2014: Second Half
December 10, 2014
Inversions Heating Up Again After Crackdown Froze Deals
November 26, 2014
Shire Backers Say AbbVie Execs Lied About Inversion Upside

Chinese Regulators OK $43B Medtronic-Covidien Inversion

Related Sections

Recent Articles By Karlee